Steru L, Chermat R, Thierry B, Simon P. 1985. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl). 85(3):367-70. doi: 10.1007/BF00428203.

Van der Heyden JA, Molewijk E, Olivier B. 1987. Strain differences in response to drugs in the tail suspension test for antidepressant activity. Psychopharmacology (Berl). 92(1):127-30. doi: 10.1007/BF00215493.

Trullas R, Jackson B, Skolnick P. 1989. Genetic differences in a tail suspension test for evaluating antidepressant activity. Psychopharmacology (Berl). 99(2):287-8. doi: 10.1007/BF00442824.

Cryan JF, Mombereau C, Vassout A. 2005. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev. 29(4-5):571-625. doi: 10.1016/j.neubiorev.2005.03.009.

Bourin M, Chenu F, Ripoll N, David DJ. 2005. A proposal of decision tree to screen putative antidepressants using forced swim and tail suspension tests. Behav Brain Res. 164(2):266-9. doi: 10.1016/j.bbr.2005.06.015.

Kulkarni SK, Dhir A. 2007. Effect of various classes of antidepressants in behavioral paradigms of despair. Prog Neuropsychopharmacol Biol Psychiatry. 31(6):1248-54. doi: 10.1016/j.pnpbp.2007.05.002.

Hariom, Kumari P, Chaturvedi S, Shrivastav S, Maratha S, Walia V. 2025. Caffeic acid differentially modulates behavior and neurochemicals in chronic unpredictable mild stress and dexamethasone induced models of depression. Pharmacol Biochem Behav. 247:173930. doi: 10.1016/j.pbb.2024.173930.